Stimulation of platelet death by vancomycin

Syeda T Towhid1, Eva-Maria Schmidt, Alexander Tolios

  • 1Department of Physiology, University of Tübingen, Germany.

Abstract

Insights

Vancomycin antibiotic can cause platelet activation and apoptosis, a form of cell death. This process involves increased calcium, caspase-3 activation, and cell shrinkage, requiring calcium but not caspases.

Area of Science:

  • Hematology
  • Immunology
  • Pharmacology

Background:

  • Vancomycin, an antibiotic, is known to cause thrombocytopenia, a decrease in platelet count.
  • This thrombocytopenia is thought to be immune-mediated, potentially involving platelet apoptosis.
  • The effect of vancomycin on platelet apoptosis has not been previously investigated.

Purpose of the Study:

  • To investigate the effect of vancomycin on platelet activation and apoptosis.
  • To elucidate the mechanisms underlying vancomycin-induced platelet apoptosis.

Main Methods:

  • Human platelets were exposed to vancomycin.
  • Assays used included forward scatter (cell volume), annexin V-binding (phosphatidylserine exposure), Fluo-3 AM fluorescence (cytosolic Ca(2+) activity), ceramide quantification, and active caspase-3 immunofluorescence.
  • Effects were assessed with and without extracellular calcium and in the presence of a caspase inhibitor.

Main Results:

  • Vancomycin (≥1 µg/ml) decreased platelet volume, induced phosphatidylserine exposure, increased cytosolic Ca(2+) activity, activated caspase-3, and stimulated ceramide formation.
  • Vancomycin also triggered thromboxane B2 release and upregulated surface expression of CD62P and activated integrin αllbβ3.
  • These effects, particularly annexin V-binding and CD62P/integrin αllbβ3 upregulation, were blunted by calcium removal but not by a caspase inhibitor.

Conclusions:

  • Vancomycin induces platelet activation and apoptosis.
  • The process involves increased cytosolic Ca(2+), caspase-3 activation, cell membrane scrambling, and cell shrinkage.
  • Platelet activation and membrane scrambling necessitate extracellular calcium, but caspase activation is not required.

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...